Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia Academic Article uri icon

Overview

MeSH Major

  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Pregnancy Complications
  • Thrombocytopenia, Neonatal Alloimmune

abstract

  • The 2 recommended protocols of intensive initial treatment followed by empiric escalation of therapy at 32 weeks of gestation are reasonably safe, effective in increasing fetal platelet counts, and allow omission of fetal blood sampling by increasing the fetal platelet count in almost all cases.

publication date

  • October 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ajog.2016.04.033

PubMed ID

  • 27131591

Additional Document Info

start page

  • 471.e1

end page

  • 9

volume

  • 215

number

  • 4